- Home
- ATLX vs CRDF Comparison
ATLX vs CRDF Comparison
Compare ATLX & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLX
- CRDF
- Stock Information
- Founded
- ATLX 2011
- CRDF 1999
- Country
- ATLX Brazil
- CRDF United States
- Employees
- ATLX N/A
- CRDF N/A
- Industry
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATLX Industrials
- CRDF Health Care
- Exchange
- ATLX Nasdaq
- CRDF Nasdaq
- Market Cap
- ATLX 156.3M
- CRDF 134.0M
- IPO Year
- ATLX N/A
- CRDF N/A
- Fundamental
- Price
- ATLX $7.93
- CRDF $2.45
- Analyst Decision
- ATLX Strong Buy
- CRDF Strong Buy
- Analyst Count
- ATLX 3
- CRDF 3
- Target Price
- ATLX $33.17
- CRDF $9.33
- AVG Volume (30 Days)
- ATLX 128.0K
- CRDF 1.1M
- Earning Date
- ATLX 11-08-2024
- CRDF 11-07-2024
- Dividend Yield
- ATLX N/A
- CRDF N/A
- EPS Growth
- ATLX N/A
- CRDF N/A
- EPS
- ATLX N/A
- CRDF N/A
- Revenue
- ATLX $543,657.00
- CRDF $688,000.00
- Revenue This Year
- ATLX N/A
- CRDF $15.00
- Revenue Next Year
- ATLX $8,970.97
- CRDF N/A
- P/E Ratio
- ATLX N/A
- CRDF N/A
- Revenue Growth
- ATLX 87586.61
- CRDF 49.57
- 52 Week Low
- ATLX $6.25
- CRDF $1.15
- 52 Week High
- ATLX $34.00
- CRDF $6.42
- Technical
- Relative Strength Index (RSI)
- ATLX 46.83
- CRDF 39.13
- Support Level
- ATLX $7.42
- CRDF $2.85
- Resistance Level
- ATLX $8.25
- CRDF $2.70
- Average True Range (ATR)
- ATLX 0.69
- CRDF 0.37
- MACD
- ATLX -0.10
- CRDF -0.12
- Stochastic Oscillator
- ATLX 28.35
- CRDF 0.36
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. They intend to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").